Trials / Completed
CompletedNCT07122349
Cannabis Impairment Detection Device Study
An Interventional Study to Facilitate the Development of a Cannabis Impairment Detection Device in Adult Cannabis Users
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 362 (actual)
- Sponsor
- Gaize · Industry
- Sex
- All
- Age
- 19 Years
- Healthy volunteers
- Accepted
Summary
The goal of this study is to develop a cannabis impairment detection device in adult cannabis users. The main question\[s\] it aims to answer are: * Is the investigational device accurate and reliable at detecting cannabis impairment? * is the device safe for the collection of eye movement data from cannabis intoxicated individuals? Participants will be administered a series of Drug Recognition Expert Ocular Tests via the Gaize headset following cannabis consumption.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | Cannabis Impairment Test | Automated Drug Recognition Expert Ocular Tests administered via VR Headset, includes test for Lack of Smooth Pursuit, Horizontal and Vertical Gaze Nystagmus, Lack of Convergence, and Pupillary Rebound Dilation. Tests are preceded by an automated system calibration process. |
Timeline
- Start date
- 2022-09-08
- Primary completion
- 2022-10-24
- Completion
- 2022-10-24
- First posted
- 2025-08-14
- Last updated
- 2025-08-17
Locations
1 site across 1 country: Canada
Source: ClinicalTrials.gov record NCT07122349. Inclusion in this directory is not an endorsement.